Expand prescription drug inflation rebates to the commercial market so drug manufacturers must pay back excess price increases.

Steven Horsford · Nevada · Democratic

policy impact 3.00 specificity 1.00 extraction confidence 96%

Contest this claim

Occurrences

The Lower Drug Costs for Families Act (H.R. 2554) would expand prescription drug inflation rebates to the commercial market, requiring drug manufactures to pay back excess price increases to lower costs for all insured Americans.

Horsford says he introduced legislation to expand drug inflation rebates to commercial insurance.

Horsford Marks 16 Years of the Affordable Care Act, Warns of Republican Healthcare Crisis Hitting Nevada Families | Congressman Steven Horsford
primary · press_release · model gpt-5.4-mini

H.R.25524 - Lower Drug Costs for Families Act ... To amend title XVIII of the Social Security Act to apply prescription drug inflation rebates to drugs furnished in the commercial market and to change the base year for rebate calculations.

Horsford is listed as leading a bill to extend prescription drug inflation rebates into the commercial market and adjust the rebate calculation base year.

Letters & Legislation | Congressman Steven Horsford
secondary · other · model gpt-5.4-mini

Evidence

The member's official homepage latest-news block in the lookback window lists June 15, 2026 DACA remarks, June 10, 2026 Social Security oversight, and June 9, 2026 digital-asset hearing remarks; it does not show any prescription-drug rebate action or commercial-market inflation-rebate announcement.

Recent official activity in the window is unrelated to the drug-rebate pledge, so this is evidence of no visible delivery signal rather than delivery itself.

unresolved same_term

Congressman Steven Horsford |
primary · model gpt-5.4-mini · confidence 83%

Contest this evidence item

The official health page states a broad commitment to affordable health care and links recent health posts about ACA tax credits, HHS cuts, and provider support, but it contains no reference to expanding prescription-drug inflation rebates into the commercial market.

The current official health framing does not document the specific commercial-market rebate policy, which supports an unresolved status rather than delivery or reversal.

unresolved same_term

Health | Congressman Steven Horsford
secondary · model gpt-5.4-mini · confidence 79%

Contest this evidence item

Assessments

unresolved unknown

The available evidence does not show that Steven Horsford delivered this specific policy outcome or materially advanced legislation that enacted commercial-market prescription-drug inflation rebates. The cited official House homepage and health-policy page show general health-care activity but no documented action on this precise rebate expansion. Because the record provided is mainly negative evidence of no visible delivery signal, the claim is best scored as unresolved rather than delivered, partial, or never.

provider codex_cli · model gpt-5.4 · confidence 79%